Oncolytic Newcastle disease virus for cancer therapy: Old challenges and new directions Journal Article


Authors: Zamarin, D.; Palese, P.
Article Title: Oncolytic Newcastle disease virus for cancer therapy: Old challenges and new directions
Abstract: Newcastle disease virus (NDV) is an avian paramyxovirus, which has been demonstrated to possess significant oncolytic activity against mammalian cancers. This review summarizes the research leading to the elucidation of the mechanisms of NDV-mediated oncolysis, as well as the development of novel oncolytic agents through the use of genetic engineering. Clinical trials utilizing NDV strains and NDV-based autologous tumor cell vaccines will expand our knowledge of these novel anticancer strategies and will ultimately result in the successful use of the virus in the clinical setting.
Keywords: interferon; apoptosis; protein; immunotherapy; colorectal-cancer; apoptosis-inducing ligand; malignant-melanoma; ndv; oncolytic; ii; active specific; hemagglutinin-neuraminidase protein; tumor-cell vaccine; ehrlich ascites tumor; bispecific fusion; selective gene-transfer; avian influenza-virus
Journal Title: Future Microbiology
Volume: 7
Issue: 3
ISSN: 1746-0913
Publisher: Future Medicine  
Date Published: 2012-03-01
Start Page: 347
End Page: 367
Language: English
ACCESSION: WOS:000301168900009
DOI: 10.2217/fmb.12.4
PROVIDER: wos
PUBMED: 22393889
PMCID: PMC4241685
Notes: --- - Review - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dmitriy Zamarin
    201 Zamarin